BD², an initiative focused on improving the understanding of bipolar disorder, is actively seeking additional clinic sites as part of its ongoing efforts to enhance research and treatment options for this mental health condition. The BD² Integrated Network currently comprises 11 clinical institutions located in both the United States and Canada, and the expansion aims to incorporate even more sites to broaden its reach and impact.
This initiative offers substantial financial support, with awards of up to $2.35 million USD available over a five-year period per clinic site. The funding is intended to facilitate the establishment of new sites within the existing network, allowing for increased research collaborations and the development of comprehensive treatment protocols for bipolar disorder.
The program’s third phase, which has recently been announced, indicates a significant commitment to advancing mental health research and improving patient outcomes. By fostering collaboration between multiple institutions, BD² aims to deepen the understanding of bipolar disorder and its treatment, ultimately benefiting individuals affected by this condition across Canada and the United States.
Analyzed Canadian Outlets (1)
1 headline